CLINICAL_TRIALS ClinicalTrials.gov record update

Idelalisib (GS-1101)-Associated Colitis - Molecular and Cellular Mechanisms Research Proposal

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02928510
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:06.579123+00:00
Published At: 2021-07-14T00:00:00+00:00
Record Updated At: 2021-07-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Absence of Signs or Symptoms", "B-Cell Non-Hodgkin Lymphoma", "Digestive System Signs and Symptoms", "Indolent Adult Non-Hodgkin Lymphoma", "Recurrent B-Cell Non-Hodgkin Lymphoma", "Recurrent Chronic Lymphocytic Leukemia", "Recurrent Indolent Adult Non-Hodgkin Lymphoma", "Recurrent Small Lymphocytic Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-07-14"
protocolSection.identificationModule.nctId: "NCT02928510"
protocolSection.identificationModule.officialTitle: "Idelalisib (GS-1101)-Associated Colitis - Molecular and Cellular Mechanisms Research Proposal"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.